The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has
been a major focus of oncology research. The p53 protein is a transcription factor that can …

The way that living cells respond to non-ionizing electromagnetic fields (EMF), including
static/extremely-low frequency and radiofrequency electromagnetic fields, fits the pattern of …

The development of targeted therapies for non-small cell lung cancer (NSCLC), such as the
epidermal growth factor receptor (EGFR), anaplastic lymphoma receptor tyrosine kinase …

Simple Summary Cancer is a complex illness marked by aberrant cellular behaviors and
genetic variances, resulting in tumor heterogeneity that presents challenges in cancer …

Simple Summary Oligometastatic disease is a condition in oncology where cancer affects
only a few distant sites. It is associated with a low-burden spread and a more favorable …

A class-A GPCR dopamine D2 receptor (D2R) plays a critical role in the proper functioning
of neuronal circuits through the downstream activation of both G-protein-and β-arrestin …

Introduction P53 is one of the most frequently mutated genes in colorectal cancer (CRC).
The present study was undertaken to provide a solid estimate of the prognostic value of p53 …

Abstract Sirtuin 1 (SIRT1) is a nicotinamide adenine dinucleotide–dependent deacetylase
that modifies gene expression through histone deacetylation. It also deacetylates …

The tumor suppressor p53 is a transcription factor involved in a variety of crucial cellular
functions, including cell cycle arrest, DNA repair and apoptosis. Still, a growing number of …

Multiple investigations indicated that Silymarin (Syl), a flavonolignan extracted from the
Silybum marianum plant, might possess anticancer properties. It is also advertised as a liver …